Related Experiment Videos
[Juvenile chronic arthritis. Double-blind study of the efficacy and tolerance of D-penicillamine]
Insights
D-Penicillamine improved joint stiffness and inflammation in children with juvenile chronic arthritis. The drug showed good tolerance, with some placebo patients also improving.
Area of Science:
- Pediatric Rheumatology
- Pharmacology
Background:
- Juvenile chronic arthritis (JCA) presents significant challenges in pediatric rheumatology.
- Current treatments aim to reduce joint inflammation and pain, improving quality of life.
Purpose of the Study:
- To evaluate the efficacy and safety of D-Penicillamine compared to placebo in children with JCA.
- To assess the impact on joint symptoms and the need for concomitant anti-inflammatory medications.
Main Methods:
- A 6-month, multicenter, double-blind, placebo-controlled study.
- Involved 74 children diagnosed with JCA, with 55 completing the trial.
- Assessed joint stiffness, pain, inflammation, and use of non-steroidal anti-inflammatory drugs (NSAIDs).
Main Results:
- D-Penicillamine treatment led to significant improvements in joint stiffness and overall disease severity.
- A notable reduction in the use of NSAIDs was observed in the D-Penicillamine group.
- Two patients experienced adverse effects, but overall tolerance was considered good.
- Some children in the placebo group also showed improvement, indicating a potential placebo effect.
Conclusions:
- D-Penicillamine demonstrates efficacy in managing juvenile chronic arthritis symptoms, including joint pain and inflammation.
- The drug is well-tolerated in the pediatric population, offering a viable treatment option.
- Further research may explore optimal D-Penicillamine dosing and long-term outcomes in JCA.
Abstract:
Seventy-four children with juvenile chronic arthritis were admitted to a 6-month multicentric double blind comparative study of the efficiency of D-Penicillamine or placebo. The results evaluated in 55 patients who completed the study, indicated an improvement in the total number of stiff joints and in the total index of severity measuring joint pain and inflammation. A significant reduction of the concurrent use of non steroidal antiinflammatory drugs was also observed. The tolerance was good except in two patients. Some children in the placebo group exhibited a definite improvement.